Immunic, Inc.
IMUX· Nasdaq
Released Aug 3, 2017, after the close
10-Q filed Aug 3, 2017, 34 days after period end · 0001280776-17-000080
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$12.41M | -$9.47M | -$15.11M | -$10.17M |
| EPS Diluted | -$0.29 | -$0.30 | -$0.63 | -$0.91 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR